MAP2K2 and cancer: Our results indicate that MEK2, but not MEK1, mediates the uptake of breast cancer cell-derived EVs by normal lung fibroblasts through micropinocytosis, and that inhibition of MEK2 could be a potential strategy to protect lung fibroblasts from cancer-secreted EVs.